Matches in SemOpenAlex for { <https://semopenalex.org/work/W4236067188> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4236067188 endingPage "1" @default.
- W4236067188 startingPage "1" @default.
- W4236067188 abstract "Back to table of contents Previous article Next article Med CheckFull AccessMed CheckNick ZagorskiNick ZagorskiSearch for more papers by this authorPublished Online:15 Dec 2017https://doi.org/10.1176/appi.pn.2017.12b53FDA Fast Tracks Alzheimer’s MedicationAlzheon Inc.’s oral anti-amyloid medication ALZ-801, a prodrug formulation of the compound tramiprosate, has been granted fast-track status by the Food and Drug Administration (FDA).Tramiprosate—which was designed to break down amyloid aggregates—failed in a previous clinical trial, but investigators found data to suggest the prodrug version could work in patients with the APOE4 risk gene. Alzheon is initiating a new phase 3 study of ALZ-801 that will specifically enroll participants who are homozygous for the risk gene and have a diagnosis of mild Alzheimer’s.FDA Committees Recommend Approval of Buprenorphine InjectableThe FDA Psychopharmacologic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee jointly voted 17-3 in favor of approving of CAM2038, a buprenorphine injection for the treatment of adults with opioid use disorder (OUD).CAM2038, developed by Braeburn Pharmaceuticals, is available in both weekly and monthly formulations. The drug is intended to be administered by health care professionals to ensure proper delivery of medication, while also minimizing risks of diversion, misuse, and accidental pediatric exposure.The committee’s recommendation was based on the results of seven clinical trials, including a phase 3 efficacy study and a long-term safety study. CAM2038 was given a priority review designation by the FDA in September.FDA Approves Implant For Sleep ApneaThe FDA in October approved an implantable neurostimulation device to treat moderate-to-severe central sleep apnea. Central sleep apnea occurs when the brain fails to send signals to the diaphragm to breathe. The resulting loss of sleep quality can lead to a range of physical and behavioral complications. The device, called the Remedē System, is an implanted nerve stimulator that sends electrical currents to the phrenic nerve to stimulate the diaphragm and restore normal breathing. The Remedē System, manufactured by Respicardia, is implanted under the skin of the upper chest. The approval was based on a clinical trial of 141 patients. After six months, more than half of the patients implanted with the active Remedē System saw at least a 50 percent reduction in their apnea hypopnea index, which measures the severity and frequency of sleep apnea, compared with only 11 percent of patients in the control group.Alkermes Submits NDA For Long-Acting Injectable InitiatorAlkermes has submitted a New Drug Application to the FDA for its novel injectable compound Aripiprazole Lauroxil NanoCrystal Dispersion. The product was designed to provide extended-release aripiprazole in a formulation that enables faster dissolution and leads to more rapid achievement of therapeutic levels of aripiprazole.If approved, administration of this product in conjunction with a single oral dose of 30 mg aripiprazole could replace the need for three weeks of concominant oral aripiprazole following the first injection of the extended-release formulation of aripiprazole, according to the company.“Patients with schizophrenia are particularly vulnerable to nonadherence and relapse when transitioning from inpatient care to outpatient settings,” said Alkermes’ Executive Vice President of Research and Development Elliot Ehrich, M.D., in a press release. “The ability to initiate long-acting treatment with Aristada on Day 1 without the need to continue oral supplementation during this critical transition period may be a useful and welcomed option for the clinical community.” ■ ISSUES NewArchived" @default.
- W4236067188 created "2022-05-12" @default.
- W4236067188 creator A5090176075 @default.
- W4236067188 date "2017-12-15" @default.
- W4236067188 modified "2023-09-26" @default.
- W4236067188 title "Med Check" @default.
- W4236067188 doi "https://doi.org/10.1176/appi.pn.2017.12b53" @default.
- W4236067188 hasPublicationYear "2017" @default.
- W4236067188 type Work @default.
- W4236067188 citedByCount "0" @default.
- W4236067188 crossrefType "journal-article" @default.
- W4236067188 hasAuthorship W4236067188A5090176075 @default.
- W4236067188 hasConcept C126322002 @default.
- W4236067188 hasConcept C170493617 @default.
- W4236067188 hasConcept C17744445 @default.
- W4236067188 hasConcept C2776876202 @default.
- W4236067188 hasConcept C2778949969 @default.
- W4236067188 hasConcept C2780035454 @default.
- W4236067188 hasConcept C2781063702 @default.
- W4236067188 hasConcept C3017489713 @default.
- W4236067188 hasConcept C3018890749 @default.
- W4236067188 hasConcept C3116431 @default.
- W4236067188 hasConcept C512399662 @default.
- W4236067188 hasConcept C535046627 @default.
- W4236067188 hasConcept C71924100 @default.
- W4236067188 hasConcept C98274493 @default.
- W4236067188 hasConceptScore W4236067188C126322002 @default.
- W4236067188 hasConceptScore W4236067188C170493617 @default.
- W4236067188 hasConceptScore W4236067188C17744445 @default.
- W4236067188 hasConceptScore W4236067188C2776876202 @default.
- W4236067188 hasConceptScore W4236067188C2778949969 @default.
- W4236067188 hasConceptScore W4236067188C2780035454 @default.
- W4236067188 hasConceptScore W4236067188C2781063702 @default.
- W4236067188 hasConceptScore W4236067188C3017489713 @default.
- W4236067188 hasConceptScore W4236067188C3018890749 @default.
- W4236067188 hasConceptScore W4236067188C3116431 @default.
- W4236067188 hasConceptScore W4236067188C512399662 @default.
- W4236067188 hasConceptScore W4236067188C535046627 @default.
- W4236067188 hasConceptScore W4236067188C71924100 @default.
- W4236067188 hasConceptScore W4236067188C98274493 @default.
- W4236067188 hasIssue "24" @default.
- W4236067188 hasLocation W42360671881 @default.
- W4236067188 hasOpenAccess W4236067188 @default.
- W4236067188 hasPrimaryLocation W42360671881 @default.
- W4236067188 hasRelatedWork W1972804040 @default.
- W4236067188 hasRelatedWork W2071145679 @default.
- W4236067188 hasRelatedWork W2387362168 @default.
- W4236067188 hasRelatedWork W2400251176 @default.
- W4236067188 hasRelatedWork W2993607974 @default.
- W4236067188 hasRelatedWork W3003628759 @default.
- W4236067188 hasRelatedWork W3042701933 @default.
- W4236067188 hasRelatedWork W3201499866 @default.
- W4236067188 hasRelatedWork W4301195367 @default.
- W4236067188 hasRelatedWork W262764037 @default.
- W4236067188 hasVolume "52" @default.
- W4236067188 isParatext "false" @default.
- W4236067188 isRetracted "false" @default.
- W4236067188 workType "article" @default.